Outcome after initial cladribine for HCL (patient numbers)
| . | Total . | VH4-34+, HCLv . | VH4-34+, HCL . | VH4-34−, HCLv . | VH4-34−, HCL . |
|---|---|---|---|---|---|
| Patients evaluable for survival | 82 | 8 | 6 | 12 | 56 |
| Patients evaulable for response | 61 | 7 | 6 | 8 | 40 |
| Complete remission | 14 | 0 | 0 | 1 | 13 |
| Hematologic remission | 18 | 0 | 2 | 2 | 14 |
| Partial response | 10 | 0 | 0 | 1 | 9 |
| No response | 19 | 7 | 4 | 4 | 4 |
| . | Total . | VH4-34+, HCLv . | VH4-34+, HCL . | VH4-34−, HCLv . | VH4-34−, HCL . |
|---|---|---|---|---|---|
| Patients evaluable for survival | 82 | 8 | 6 | 12 | 56 |
| Patients evaulable for response | 61 | 7 | 6 | 8 | 40 |
| Complete remission | 14 | 0 | 0 | 1 | 13 |
| Hematologic remission | 18 | 0 | 2 | 2 | 14 |
| Partial response | 10 | 0 | 0 | 1 | 9 |
| No response | 19 | 7 | 4 | 4 | 4 |
HCL indicates classic hairy-cell leukemia; and HCLv, variant HCL.